PTP4A3 and cancer: In summary, we have developed the first alpaca-derived single domain antibodies against PRL-3 and showed that they could specificity detect PRL-3 in multiple in vitro assays, in human cell lysates overexpressing PRL-3, and in situ in fixed cancer cells.